Results | Institute of Oncology | Institutes and Laboratories | Structure | Research Organisation | Research | Riga Stradiņš University

Contact details

13 Pilsoņu Str., Riga, LV-1002

Phone: +371 67704028

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Results

  • Google plus

Projects

Projects funded by the Latvian Council of Science and National Research Programme

  • ERA-NET TRANSCAN projects "Mutated neo-antigens in hepatocellular carcinoma" (HEPAMUT). 2017–2019

  • ERA-NET FLAGERA projects "Information Technology: The Future of Cancer Treatment” (ITFoC). 2017–2019

  • The National Research Programme "Biomedicine for Public Health (BIOMEDICINE)", project No. 5.5 "Personalized cancer diagnostics and prediction of therapy efficacy". Duration: 2014–2017

  • Within the framework of the National Research Programme “Development of New Preventive, Treatment, Diagnostic Means and Methods, Biomedical Technologies for Improvement of Public Health” — project No. 4 “Study of clinical, molecular, and morphological correlation, early diagnosis, treatment effectiveness and patients’ quality of life of hereditary and sporadic cancer”. Duration: 2010–2014

  • Project of the Administration of Studies and Research No. 09.1603 “Strategy for Treatment of Life Expectancy and Life Quality Threatening Diseases”. Duration: 2009–2012

  • Within the framework of the National Research Programme “Study of Major Pathologies Threatening the Life Expectancy and Quality of Life in the Latvian Population by Multi-Disciplinary Research Consortium” – project “Clinical and molecular study of hereditary cancers for prevention and development of early diagnostics strategy”. Duration: 2006–2009

  • Project of the Administration of Studies and Research RSU-ZP 07-5 “Clinical and molecular studies of malignant cancers for the improvement of early diagnostics and therapeutic strategy”. Duration: 2007–2008

  • Project funded by the Latvian Council of Science No. 05.1838. “Clinical and molecular characteristics of hereditary breast and ovarian cancer in Latvia”. Duration: 2005–2008

  • Postdoctoral project funded by the Latvian Council of Science No. 05.1840. “Clinical manifestations and molecular characteristics of the predisposed gene mutations with high and low penetrance in colorectal cancer”. Duration: 2005–2008

Bilateral projects

  • European Social Fund co-financed project No. 1DP/1.1.1.2.0/13/APIA/VIAA/017. “Predictive test to evaluate efficacy of therapy of oncological patients”. Duration: 2014–2015

  • Project No. ESTLATRUS/3.2./ELRI-097/2011/06 “Formation of Hereditary Cancer Prevention Measures in Pskov Region” co-financed by the programme “Estonia-Latvia-Russia Cross-border Collaboration 2007-2013”. Duration: 2012–2013

  • Project No. LLB-1-090 „The Development of modern breast cancer awareness, prevention, early detection and management measures in border regions of Latvia, Lithuania and Belarus” co-financed by the programme "Latvia-Lithuania-Belarus cross-border collaboration 2007-2013". Duration: 2011–2013

  • European Social Fund co-financed project No. 2009/0230/1DP/1.1.1.2.0/09/APIA/VIAA/070. “Creation of a new interdisciplinary research team to investigate breast cancer and to increase the efficacy of therapy and the patient’s quality of life”. Duration: 2010–2013

Publications

2016

  • Plonis J., Kalniete D., Nakazawa-Miklasevica M., Irmejs A, E.Vjaters, Gardovskis J.,Miklasevics E. The CHEK2 del15395 is a founder mutation without direct effects for cancer riski n the Latvian population, 2015; BJMG N 18 (2), 33-36.

  • Youngstrom D.W., Cakstina I., Jakobsons E. Cartilage-derived extracellular matrix extract promotes chondrocytic phenotype in three-dimensional tissue culture. Artif Cells Nanomend Biotechnol. 2015; Feb24:1-8.

  • Kalniete D., Nakazawa-Miklasevica M., Strumfa I., Abolins A., Irmejs A., Gardovskis J., Miklasevics E. High expression of mir-214 is associated with worse disease-specific survival of the triple-negative breast cancer patients. Hereditary Cancer in Clinical Practice 2015; 13:7.

  • Plonis J., Nakazawa-Miklasevica M., Malevskis A., Vaganovs P., Pildava S., Vjaters E., Gardovskis J., Miklasevics E. Survival rates of familial and sporadic prostate cancer patients. Exp. Oncol., 2015; 37, 154 – 155.

  • Serrano-Fernandez P., Dymerska D., Kurzawski G., Derkacz R., Sobieszczanska T., Banaszkiewicz Z., Roomere H., Oitmaa E., Metspalu A., Janavicius R., Elsakov P., Razumas M., Petrulis K., Irmejs A., Miklaševics E., Rodney J. S., Lubinski J. Cumulative small effect genetic markers and the risk of colorectal cancer in Poland, Estonia, Lithuania and Latvia. Gastroenterology Res. Practice, 2015; Article ID 204089.

  • Ustinova M., Daneberga Z., Bērziņa D., Nakazawa-Miklaševiča M., Maksimenko J., Gardovskis J., Miklaševičs E. Impact of KRAS variant rs61764370 on breast cancer morbidity. Exp. Oncol., 2015; 37, 292 – 294.

  • Daneberga Z., Broka E., Kalniete D., Nakazawa-Miklasevica M., Ustinova M., Skuja E., Purkalne G., Miklasevics E. Plasma miR-21 and miR-31 as Predictive Biomarkers for Evaluation of Therapeutic Efficacy in Metastatic Colorectal Cancer, 2015, ACTA CHIRURGICA LATVIENSIS, 15/1: 3-7.

  • Miklasevics E., Kupila M., Kalniete D., Eglite I., Berzina D., Ustinova M., Purkalne G., Daneberga Z.. Chromosomal Aberration in Colorectal Cancer Family, 2015; ACTA CHIRURGICA LATVIENSIS, 15/1: 8-11.

2015

  • Chromosomal aberration in colorectal cancer family / E. Miklasevics, D. Kalniete, D. Berzina, M. Ustinova, G. Purkalne, Z. Daneberga ...[et al.] // Acta Chirurgica Latviensis. - No.15/1 (2015), p.8-11.

  • The CHEK2 del15395 is a founder mutation without direct effects for cancer riski n the Latvian population / J. Plonis, GD. Kalniet, M. Nakazawa-Miklasevica, A. Irmejs, E. Vjaters, J. Gardovskis, E. Miklasevics // // BJMG N 18 (2), 2015, P.33-36.
  • Youngstrom D.W., Cakstina I., Jakobsons E. Cartilage-derived extracellular matrix extract promotes chondrocytic phenotype in three-dimensional tissue culture. Artif Cells Nanomend Biotechnol. 2015; Feb24:1-8.

  • Kalniete D., Nakazawa-Miklasevica M., Strumfa I., Abolins A., Irmejs A., Gardovskis J., Miklasevics E. High expression of mir-214 is associated with worse disease-specific survival of the triple-negative breast cancer patients. Hereditary Cancer in Clinical Practice 2015, 2015, 13:7.

  • Plonis J., Nakazawa-Miklasevica M., Malevskis A., Vaganovs P., Pildava S., Vjaters E., Gardovskis J., Miklasevics E. Survival rates of familial and sporadic prostate cancer patients. Exp. Oncol., 2015, 37, 154 - 155.

  • Serrano-Fernandez P., Dymerska D., Kurzawski G., Derkacz R., Sobieszczanska T., Banaszkiewicz Z., Roomere H., Oitmaa E., Metspalu A., Janavicius R., Elsakov P., Razumas M., Petrulis K., Irmejs A., Miklaševics E., Rodney J. S., Lubinski J. Cumulative small effect genetic markers and the risk of colorectal cancer in Poland, Estonia, Lithuania and Latvia. Gastroenterology Res. Practice, 2015, Article ID 204089.

  • Ustinova M., Daneberga Z., Bērziņa D., Nakazawa-Miklaševiča M., Maksimenko J., Gardovskis J., Miklaševičs E. Impact of KRAS variant rs61764370 on breast cancer morbidity. Exp. Oncol., 2015, 37, 292 - 294.

  • Zanda Daneberga, Elza Broka, Dagnija Kalniete, Miki Nakazawa-Miklasevica, Monta Ustinova, Elina Skuja, Gunta Purkalne, Edvins Miklasevics. Plasma miR-21 and miR-31 as Predictive Biomarkers for Evaluation of Therapeutic Efficacy in Metastatic Colorectal Cancer, 2015, ACTA CHIRURGICA LATVIENSIS, 15/1: 3-7.

  • Edvins Miklasevics, Mikko Kupila, Dagnija Kalniete, Inese Eglite, Dace Berzina, Monta Ustinova, Gunta Purkalne, Zanda Daneberga. Chromosomal Aberration in Colorectal Cancer Family, 2015, ACTA CHIRURGICA LATVIENSIS, 15/1: 8-11.

2014

  • Cakstina I., Riekstina U., Boroduskis M., Nakurte I., Ancans J., Zile M. H., Muiznieks I. Primary culture of avian embryonic heart forming region cells to study the regulation of vertebrate early heart morphogenesis by vitamin A. BMC Dev Biol., 2014; 19;14(1):10.

  • Latkovskis G., Urtane I., Knipse A., Peculis R., Cakstina I., Klovins J., Ergils A. Role of genetic factors on the effect of additional loading doses and two maintenance doses used to overcome clopidogrel hyporesponsiveness. Medicina (Kaunas). 2014; 50(1):19-27.

  • Cakstina I., Riekstina U., Boroduskis M., Muiznieks I. Primary culture of avian embryonic heart forming region cells to study the regulation of vertebrate early heart morphogenesis by vitamin A. BMC Developmental Biology. 2014; Feb 19;14:10.

  • Pogodina J., Ribenieks R., Berzina D., Trofimovics G., Miklasevics E. CDH1 mutation in two patients with hereditary gastric cancer. Acta Chirurgica Latviensis, 2014, N14/1, 35 - 37.

  • Dymerska D., Kurzawski G., Suchy J., Roomere H., Toome K., Metspalu A., Janavičius R., Elsakov P., Irmejs A., Berzina D., Miklaševičs E., Gardovskis J., Rebane E., Kelve M., Kładny J., Huzarski T., Gronwald J., Dębniak T., Byrski T., Stembalska A., Surdyka D., Siołek M., Szwiec M., Banaszkiewicz Z., Wiśniowski R., Kilar E., Scott R., Lubiński J. Lynch syndrome mutations shared by the Baltic States and Poland. Clin. Genet., 2014, 86, 190 - 193.

  • Reste J., Zvigule G., Zvagule T., Kurjane N., Eglite M., Gabruseva N., Berzina D., Plonis J., Miklasevics E. Telomere length in Chernobyl accident recovery workers in the late period after the disaster. J. Radiat. Res., 2014, 55, 1089 - 1100.

  • Plonis J., Bokums K., Cauce V., Miklasevics E., Vaganovs P., Irmejs A., Gardovskis J., Vjaters E. Prostate cancer trends in Latvia during 1990 - 2012: Incidence, prevalence, mortality and survival rates. Medicina (Kaunas), 2014, 50, 313 - 317.

  • Pranka M., Dzervite A., Rungule R., Lace T., Miklasevics E., Gardovskis J. Assessment of life quality factors by breast cancer patients. SHS Web of Conferences: Proceedings. - vol. 10 (2014): 4th International Interdisciplinary Scientific Conference “Society. Health. Welfare” (Riga, Latvia, Nov. 22 - 23, 2012) / - 00034-p.1-00034-p10.

  • Svampane L., Strumfa I., Berzina D., Svampans M., Miklasevics E., Gardovskis J. Epidemiological analysis of hereditary endometrial cancer in a large study population. Arch. Gynecol. Obstet., 2014, Epub ahead of print.

  • Maksimenko J., Irmejs A., Nakazawa-Miklasevica M., Melbarde-Gorkusa I., Trofimovics G., Gardovskis J., Miklasevics E. Prognostic role of BRCA1 mutations in patients with triple-negative breast cancer. Oncology Letters, 2014, 7, 278 - 284.

2013

  • Skuja E., Sorubalko A., Purkalne G., Miklasevics E. Neoadjuvant Chemoradiation in Patient with Localy Advanced Rectal Cancer. Acta Chirurgica Latviensis, 2014 (13/1)

  • Dymerska D., Kurzawski G., Suchy J., Roomere H., Toome K., Metspalu A., Janavičius R., Elsakov P., Irmejs A., Berzina D., Miklaševičs E., Gardovskis J., Rebane E., Kelve M., Kładny J., Huzarski T., Gronwald J., Dębniak T., Byrski T., Stembalska A., Surdyka D., Siołek M., Szwiec M., Banaszkiewicz Z., Wiśniowski R., Kilar E., Scott R., Lubiński J. Lynch syndrome mutations shared by the Baltic States and Poland. Clin Genet. 2013; 5. DOI: 10.1111/cge.12251
  • Kalniete D., Nakazawa-Miklasevica M., Strumfa I., Abolins A., Irmejs A., Trofimovics G., Gardovskis J., Miklasevics E. MicroRNA Expression in Different Sybtypes of Breast Cancer. Acta Chirurgica Latviensis, 2013; 13, (1): 7–12. DOI: 10.2478/chilat-2013-0002

  • Dzervite A., Pranka M., Lace T., Rungule R., Gardovskis J., Miklasevics E. Initial Findings of Breast Cancer Risk Factors from a Survey Conducted at Pauls Stradins Clinical University Hospital. Acta Chirurgica Latviensis, 2013; 13, (1): 34–38. DOI: 10.2478/chilat-2013-0007

  • Pogodina J., Trofimovics G., Miklasevics E., Ribenieks R. Hereditary Gastric Cancer: Review of Literature. Acta Chirurgica Latviensis. 2013; 13, (1): 71–74. DOI: 10.2478/chilat-2013-0013

  • Vaganovs P., Bokums K., Miklaševics E., Plonis J., Zarina L., Geldners I., Gardovskis J., Vjaters E. Von hippel-lindau syndrome: diagnosis and management of hemangioblastoma and pheochromocytoma. Case Rep Urol., 2013. PMID: 23781388

  • Berzina D., Nakazawa-Miklasevica M., Zestkova J., Aksenoka K., Irmejs A., Gardovskis A., Kalniete D., Gardovskis J., Miklasevics E. BRCA1/2 mutation screening in high-risk breast/ovarian cancer families and sporadic cancer patient surveilling for hidden high-risk families. BMC Med Genet, 2013; 14(1):61. PMID: 23767878

  • Plakhins G., Gardovskis A., Subatniece S., Liepniece-karele I., Purkalne G., Teibe U., Trofimovičs G., Miklaševičs E., Gardovskis J. Underestimated survival predictions of the prognostic tools Adjuvant! Online and PREDICT inBRCA1 – associated breast cancer patients. Fam Cancer, 2013; 3. PMID: 23640109

  • Saule M., Samuelsen Ø., Dumpis U., Sundsfjord A., Karlsone A., Balode A., Miklasevics E., Karah N. Dissemination of a carbapenem-resistant Acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia. Antimicrob Agents Chemother. 2013;57(2):1069-72. PMID: 23229482

  • Svampane L., Strumfa I., Berzina D., Svampans M., Miklasevics E., Gardovskis J. Epidemiological analysis of hereditary endometrial cancer in a large study population. Arch Gynecol Obstet. 2013; PMID: 24292105

2012

  • Vanags A., Štrumfa I., Gardovskis A., Āboliņš A., Simtniece Z., Trofimovičs G., Gardovskis J., The first evidence of hereditary and familial gastric cancer in Latvia: implications for prevention. Medicina (Kaunas), 2012; 48: 317–323. PMID: 22885366

  • Melbārde-Gorkuša I., Irmejs A., Bērziņa D., Strumfa I., Aboliņš A., Gardovskis A., Subatniece S., Trofimovičs G., Gardovskis J., Miklaševičs E. Challenges in the management of a patient with Cowden syndrome: case report and literature review. Hered Cancer Clin Pract, 2012; 14, 10 (1):5. PMID: 22503188

  • Tulin A., Ribenieks R., Pogodina J., Stucka R., Shavlovskis J., Gardovskis J., Diagnostics and surgical treatment of liver echinococcosis in Latvia. Vestn Khir Im I I Grek, 2012;171(1):38-44. PMID:22645914 PMID:22645914

  • Simtniece Z., Strumfa I., Abolins A, Vanags A., Gardovskis J. Prognostic factors after curative resection of pancreatic ductal adenocarcinoma: a retrospective study. Journal of Cancer Therapeutics and Research, 2012. DOI: HTR

  • Skuja E., Āboliņš A., Priedīte I., Purkalne G., Štrumfa I., Vilmanis J., Kalniete D., Miklaševičs E., Gardovskis J. Pathological Complete Remission in Young Colon Cancer Patient with a Large Liver Metastasis after FOLFOX-4/Bevacizumab Treatment—A Case Report. Int. J. Clinical Med., 2012; 3: 307-310. IJCM2012

  • Ozolins A., Narbuts Z., Strumfa I., Volanska G., Stepanovs K., Gardovskis J. Immunohistochemical Expression of HBME-1, E-cadherin, and CD56 in the Differential Diagnosis of Thyroid Nodules. Medicina (Kaunas), 2012;48(10):507-14. PMID:23324246

  • Bērziņš D., Irmejs A., Kalniete D., Borošenko V., Nakazawa-Miklasevica M., Rībenieks K., Trofimovič G., Gardovskis J., Miklaševič E. Novel germline MLH1 and MSH2 mutations in Latvian Lynch syndrome families. Exp. Oncol., 2012; 34, 1–4. PMID:22453149

  • Čupāne L., Pugačova Ņ., Bērziņa D., Cauce V., Gardovska D., Miklaševičs E. Patients with PVL positive S. aureus infections run an increased risk of longer hospitalisation. Int. J. Mol. Epidemiol. Genet., 2012; 3(1), 48–55. PMID:22493751

  • Dzērvīte A., Pranka M., Lace T., Rungule R., Miklasevics E., Gardovskis J. Key Factors Contributing to Quality of Life for Breast Cancer Patients in Latvia: Supplementing Quantitative Surveys with Qualitative Interviews. Acta Chirurgica Latviensis, 2012; 12, (1): 3–10. DOI: 10.2478/v10163-012-0001-0

  • Maksimenko J., Irmejs A., Trofimovics G., Miklasevics E. Breast – conserving Surgery in Early – Stage Triple – Negative Breast Cancer: Is There a Higher Risk of Locoregional Recurrence? Acta Chirurgica Latviensis, 2012; 12,(1):11–14. DOI: 10.2478/v10163-012-0002-z

  • Skuja E., Purkalne G., Miklasevics E. Unresectable Metastatic Colorectal Cancer Treatment and Survival – Pauls Stradins Clinical University Hospital Experience. Acta Chirurgica Latviensis, 2012; 12, (1):15–19. DOI: 10.2478/v10163-012-0003-y

  • Strumfa I., Vanags A., Abolins A., Gardovskis J. Pathology of Breast Cancer: from Classic Concepts to Molecular Pathology and Pathogenesis. Acta Chirurgica Latviensis, 2012; 12 (1):59–66. DOI: 10.2478/v10163-012-0012-x

  • Vanags A., Sneidere M., Strumfa I., Simtniece Z., Pavars M., Gardovskis J. Recurrent Gallstone Ileus in an Elderly Patient With Significant Co-Morbidity. Acta Chirurgica Latviensis, 2012;12, (1):78–80. DOI: 10.2478/v10163-012-0015-7

  • Abolins A., Strumfa I., Vanags A., Trofimovics G., Gardovskis J. Granular Cell Tumour of the Breast Cancer: Challenging Clinical and Radiological Mimic of Cancer. Acta Chirurgica Latviensis, 2012; 12, (1):84–86. DOI: 10.2478/v10163-012-0017-5

  • Simtniece Z., Strumfa I., Abolins A., Vanags A., Gardovskis J. Prognostic factors after curative resection of pancreatic ductal adenocarcinoma: a retrospective study. J. Cancer Therapeutics Res., 2012; DOI: 10.7243/2049-7962-1-27

2011

  • Abolins A., Vanags A., Trofimovics G., Miklasevics E., Gardovskis J., Strumfa I. Molecular subtype shift in breast cancer upon trastuzumab treatment. A case report. Pol. J. Pathol. 2011; 62 (1): 65–68. PMID: 21034437

  • Plakhins G., Irmejs A., Gardovskis A., Subatniece S., Rozīte S., Bitina M., Keire G., Purkalne G., Teibe U., Trofimovičs G., Miklaševičs E., Gardovskis J. Genotype-phenotype correlations among BRCA1 4153delA and 5382insC mutation carriers from Latvia. BMC Med Genet. 2011; 12: 147. PMID: 22032251.

  • Abele A., Vjaters E., Irmejs A., Trofimovičs G., Miklaševičs E., Gardovskis J. Epidemiological, clinical and molecular characteristics of hereditary prostate cancer in Latvia. Medicina (Kaunas), 2011; 47 (10): 579-585. PMID: 22186123

  • Kalniete D., Irmejs A., Štrumfa I., Žestkova J., Aksenoka K., Gardovskis J., Miklaševičs E. Detection of Large Deletions and Duplications in Moderate Risk Breast Cancer Susceptibility Genes in Breast Cancer Patients Negative for the BRCA1 and BRCA2 Mutations. Acta Chirurgica Latviensis, 2011;11, (1):3.

  • Abolins A., Vanags A., Strumfa I., Melbarde-Gorkusa I., Abolina M., Trofimovics G., Miklasevics E., Gardovskis J. Primary Breast Lymphoma: Clinical and Morphological Characteristics. Acta Chirurgica Latviensis, 2011;11, (1):9.

  • Maksimenko J., Liepniece-Karele I., Irmejs A., Trofimovics G. The Clinicopathologic Characteristics and Prognostic Significance of Triple - Negative Invasive Breast Cancer Phenotype. Acta Chirurgica Latviensis, 2011;11, (1):16.

  • Abolins A., Strumfa I., Vanags A., Trofimovics G., Gardovskis J. Histological and Immunohistochemical Evaluation of Cytokeratin 5/6 Expressing Breast Cancer. Acta Chirurgica Latviensis, 2011;11, (1):28.

  • Simtniece Z., Vanags A., Strumfa I., Pavars M., Gardovskis J. Prognostic Factors in Potentially Radically Operated Pancreatic Carcinoma. Acta Chirurgica Latviensis, 2011;11, (1):34.

  • Ozolins A., Narbuts Z., Strumfa I., Volanska G., Prieditis P., Stepanovs K., Gardovskis J. Immunocytochemistry as an Adjunct to Fine-needle Aspiration of Thyroid in Distinction Between Benign and Malignant Thyroid Neoplasms. Acta Chirurgica Latviensis, 2011;11, (1):39.

  • Melbarde-Gorkusa I., Strumfa I., Vanags A., Trofimovics G., Gardovskis J. Pathological Features of BRCA1/BRCA2 Mutation-Associated Breast Cancer: Implications for Diagnostics and Treatment. Acta Chirurgica Latviensis, 2011;11, (1): 114–121 DOI: 10.2478/v10163-012-0022-8

  • Vanags A., Grusina-Ujumaza J., Strumfa I., Ambalovs G., Abolins A., Gardovskis J. Primary Bronchus-Associated Lymphoid Tissue (BALT) Lymphoma. Acta Chirurgica Latviensi, 2011; 11 (1): 144–147. DOI: 10.2478/v10163-012-0028-2

  • Melbarde-Gorkusa I., Strumfa I., Irmejs A., Abolins A., Miklasevics E., Gardovskis A., Subatniece S., Trofimovics G., Gardovskis J. Management of BRCA1 Mutation Carrier with Breast Cancer. Acta Chirurgica Latviensis, 2011; 11 (1): 148–150. DOI: 10.2478/v10163-012-0029-1

  • Vanags A., Strumfa I., Abolins A., Brikuns A., Simtniece Z., Gardovskis J. Primary Adenocarcinoma of the Appendix. Acta Chirurgica Latviensis, 2011; 11 (1): 151–153. DOI: 10.2478/v10163-012-0030-8

  • Vjaters E., Strumfa I., Vejins M., Abele A., Trofimovics G., Gardovskis J. Incidental Primary Non-Hodgkin's Lymphoma of the Prostate in a Patient with Prostate Cancer: A Case Report. Acta Chirurgica Latviensi, 2011; 11; (1): 154–155. DOI: 10.2478/v10163-012-0031-7

  • Melbarde-Gorkusa I., Abolins A., Strumfa I., Martinsons A., Gardovskis J. Human Dirofilariasis in Latvia - the First Case in Surgical Practice. Acta Chirurgica Latviensi, 2011; 11 (1): 172–174. DOI: 10.2478/v10163-012-0037-1

2010

  • Dumpis U., Iversen A., Balode A., Saule M., Miklasevics E., Giske CG.: Outbreak of CTX-M-15-producing Klebsiella pneumoniae of sequence type 199 in a Latvian teaching hospital. APMIS, 2010; Vol. 118 (9): 713–716. PMID:20718724

  • Zavadska D., Berzina D., Drukalska L., Pugacova N., Miklasevics E., Gardovska D. Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia. APMIS, 2010; Vol. 118 (5): 366–370. PMID:20477812

  • Vanags A., Strumfa I., Gardovskis A., Borosenko V., Abolins A., Teibe U., Trofimovics G., Miklasevics E., Gardovskis J. Population screening for hereditary and familial cancer syndromes in Valka district of Latvia. Hered. Cancer Clin. Pract., 2010; 8 (1):8. PMID:21034437

  • Ozolins A., Narbuts Z., Strumfa I., Volanska G., Gardovskis J. Diagnostic utility of immunohistochemical panel in various thyroid pathologies. Langenbecks Arch Surg., 2010; 395(7):885–891. PMID:20640858

  • Vanags A., Strumfa I., Gardovskis A., Melbarde-Gorkusa I., Abolins A., Trofimovics G., Gardovskis J. The Characteristics of Hereditary Colorectal Cancer Syndromes by Population Screening. Acta Chirurgica Latviensis, 2010; 10 (2):3–8. DOI: 10.2478/v10163-011-0001-5

  • Vanags A., Strumfa I., Gardovskis A., Melbarde-Gorkusa I., Abolins A., Trofimovics G., Gardovskis J. The Upgrade of Hereditary Cancer Surveillance Schedule by Valka District Population Screening Data. Acta Chirurgica Latviensis, 2010; 10 (2): DOI: 10.2478/v10163-011-0002-4

  • Vanags A., Strumfa I., Abolins A., Gardovskis A., Melbarde-Gorkusa I., Trofimovics G., Gardovskis J. The Concept, Diagnostics, Surgical Prevention and Treatment of Hereditary Colorectal Cancer in Nowadays Medicine. Acta Chirurgica Latviensis, 2010; 10 (2):80–85. DOI: 10.2478/v10163-011-0016-y

  • Ozolins A., Narbuts Z., Strumfa I., Prieditis P., Gardovskis J. Diagnosis and Management of the Thyroid Nodules. Acta Chirurgica Latviensis, 2010; 10 (2):86–90. DOI: 10.2478/v10163-011-0017-x

  • Abolins A., Vanags A., Volanska G., Melbarde-Gorkusa I., Strumfa I., Trofimovics G., Gardovskis J. Malignant Peripheral Nerve Sheath Tumour of the Breast in Complex Clinical Background. Acta Chirurgica Latviensis, 2010; 10 (2): DOI: 10.2478/v10163-011-0022-0

  • Cupane L., Pugacova N., Aleksejevs G., Berzina D., Gardovska D., Miklasevics E. Methicillin Susceptible Panton - Valentine Leukocidin Positive S. Aureus Pneumonia in a Child with Novel Influenza H1N1 Infection. Acta Chirurgica Latviensis. 2010; 10 (2):127–130. DOI: 10.2478/v10163-011-0027-8

2009

  • Kaufman B., Laitman Y., Gronwald J., Winqvist R., Irmejs A., Lubinski J., Pylkas K., Gardovskis J., Miklasevics E., Friedman E. Haplotypes of the I157T CHEK2 germline mutation in ethnically diverse populations. Fam. Cancer, 2009; 8(4): 473–478. PMID:19609724

  • Borosenko V., Irmejs A., Melbarde-Gorkusa I., Gardovskis A., Pavars M., Vanags A., Trofimovics G., Miklasevics E., Gardovskis J. Initial Results of Colorectal Polyposis Research in Latvia. Anticancer Res. 2009; Vol. 29: 711– 715. PMID:19331226

  • Vanags A., Grushina J., Strumfa I., Gardovskis J. The First Evidence of Familial Lung Cancer in Latvia by Population Screening for Hereditary Cancer. Acta Chirurgica Latviensis, 2009; 9 (1):3–9. DOI: 10.2478/v10163-010-0001-x

  • Ozolins A., Pavars M., Gardovskis J. First Experience in Quality of Life Analysis After Bariatric Surgery. Acta Chirurgica Latviensi. 2009; 9 (1): 16–20. DOI: 10.2478/v10163-010-0003-8

  • Aksenoka K., Balode A., Grope I., Obidenova T., Gardovska D., Miklasevics E. Clostridium difficile Associated Disease Clinical and Molecular Data. Acta Chirurgica Latviensis, 2009; 9 (1): DOI: 10.2478/v10163-010-0011-8

  • Vanags A., Pavars M., Prieditis P., Strumfa I., Irmejs A., Gardovskis J. Biliary Cystic Tumours with Mesenchymal Stroma. Acta Chirurgica Latviensis, 2009; 9 (1): 95–99. DOI: 10.2478/v10163-010-0019-0

  • Vanags A., Strumfa I., Pavars M., Gardovskis J. Intragastric Migration of Swedish Adjustible Gastric Band. Acta Chirurgica Latviensis, 2009; 9 (1): 105–107. DOI: 10.2478/v10163-010-0021-6

2008

  • Irmejs, A, Miklasevics, E, Strumfa, I, Gardovskis, J: Comment on the article Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour patholo. Hered. Cancer Clin. Pract., 2008; 6(2): 66. PMID:19804597

2007

  • Elsakov P., Foretova L., Goetz P., de Groot JWB, van der Graaf WTA, Guler G., Huebner K., Haites NE., Hamann U., Ho J., Imyanitov EN., Irmejs A., Purkalne G., Bitina M., Gardovskis A., Gardovskis J., Kirova YM., Fourquet A., Pierga JY., Stoppa-Lyonnet. Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers. Hered. Cancer Clin. Pract., 2007; 5: 119 – 143. HCCP

  • Bratslavska O., Platace D., Miklasevics E., Fuchs D., Martinsons A. Influence of neopterin and 7,8-dihydroneopterin on the replication of Coxsackie type B5 and influenza A viruses. Med. Microbiol. Immunol., 2007; 196 (1): 23–29. PMID:16868770

  • Irmejs A., Borosenko V., Melbarde-Gorkusa I., Gardovskis A., Bitina M., Kurzawski G., Suchy J., Gorski B., Gardovskis J. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia. Anticancer Res., 2007; 27(1B):653–658. PMID: 17348456

2006

  • Irmejs A., Miklasevics E., Boroschenko V., Gardovskis A., Vanags A., Melbarde-Gorkusa I., Bitina M., Suchy J., Gardovskis J.: Pilot study on low penetrance breast and colorectal cancer predisposition markers in Latvia. Hered Cancer Clin Prac., 2006; 4(1):48-51. PMID:20223004


Doctoral Theses

2015

2014

2013

2011

2010

2008

  • Andris Gardovskis: Clinical and Molecular Features of Hereditary Breast/Ovarian Cancer in Latvia. Scientific supervisor: Dr. habil. med., Prof. Jānis Gardovskis

onko-inst-btm00


Rīga Stradiņš University, 16 Dzirciema Street, Rīga, LV-1007, Latvia, +371 67409261 (UTC +2), international@rsu.lv